The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Self-citationLyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
[1] Preparation of monoclonal antibodies: Strategies and procedures
Galfrè, G., & Milstein, C. (1981) · Methods in Enzymology · doi:10.1016/0076-6879(81)73054-4 · Cited by 1,771
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Self-citationCasanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Self-citationNozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Gordon, M. S., Margolin, K., Talpaz, M., Sledge, G. W., Holmgren, E., Benjamin, R., Stalter, S., Shak, S., & Adelman, D. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.843 · Cited by 913
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
Self-citationAnti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Self-citationFernández, M., Semela, D., Bruix, J., Colle, I., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 600
Self-citationFLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2524 · Cited by 568
Self-citationWillett, C. G., Boucher, Y., Duda, D. G., di Tomaso, E., Munn, L. L., Tong, R. T., Kozin, S. V., Petit, L., Jain, R. K., Chung, D. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5635 · Cited by 420
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
Loges, S., Mazzone, M., Hohensinner, P., & Carmeliet, P. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.007 · Cited by 393
Self-citationExperimental mouse models for hepatocellular carcinoma research
Heindryckx, F., Colle, I., & Van Vlierberghe, H. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00656.x · Cited by 367
Self-citationRakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Noe¨l, A., & Munaut, C. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1092 · Cited by 321
Self-citationThrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
Streit, M., Riccardi, L., Velasco, P., Brown, L. F., Hawighorst, T., Bornstein, P., & Detmar, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14888 · Cited by 302
Self-citationFibroblast growth factors are required for efficient tumor angiogenesis.
Compagni, A., Wilgenbus, P., Impagnatiello, M.-A., Cotten, M. L., & Christofori, G. (2000) · PubMed · Cited by 258
Self-citationHypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
Wu, X., Xie, G., & Chen, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04997.x · Cited by 212
Wu, Y., Hooper, A. T., Zhong, Z., Witte, L., Bohlen, P., Rafii, S., & Hicklin, D. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21865 · Cited by 192
A critical role of placental growth factor in the induction of inflammation and edema formation
Oura, H., Bertoncini, J., Velasco, P., Brown, L. F., Carmeliet, P., & Detmar, M. (2003) · Blood · doi:10.1182/blood-2002-05-1516 · Cited by 176
Self-citationMaes, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26772 · Cited by 172
Landgren, E., Schiller, P., Cao, Y., & Claesson-Welsh, L. (1998) · Oncogene · doi:10.1038/sj.onc.1201545 · Cited by 168
Self-citationPavco, P. A., Bouhana, K., Gallegos, A. M., Agrawal, A., Blanchard, K. S., Grimm, S., Jensen, K. L., Andrews, L. E., Wincott, F. E., PITOT, P. A., et al. (2000) · PubMed · Cited by 160
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Bais, C., Wu, X., Yao, J. J., Yang, S., Crawford, Y., McCutcheon, K. M., Tan, C., Kolumam, G. A., Vernes, J.-M., Eastham‐Anderson, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.033 · Cited by 159
Placental Growth Factor Promotes Atherosclerotic Intimal Thickening and Macrophage Accumulation
Khurana, R., Moons, L., Shafi, S., Luttun, A., Collen, D., Martin, J. F., Carmeliet, P., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.104.495887 · Cited by 158
Self-citationWu, Y. L., Zhong, Z., Huber, J., Bassi, R., Finnerty, B., Corcoran, E., Li, H., Navarro, E. C., Balderes, P. J., Jimenez, X., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0831 · Cited by 152
Hawighorst, T., Velasco, P., Streit, M., Hong, Y., Kyriakides, T. R., Brown, L. F., Bornstein, P., & Detmar, M. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2631 · Cited by 148
Self-citationPlacenta growth factor is over-expressed and has prognostic value in human breast cancer
Parr, C., Watkins, G., Boulton, M. E., Cai, J., & Jiang, W. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.022 · Cited by 140
Chen, C., Hsieh, F., Cheng, Y.-M., Cheng, W.-F., Su, Y.-N., Chang, K., & Lee, P. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.05.020 · Cited by 131
Wittko, I. M., Schänzer, A., Kuzmichev, A., Schneider, F. T., Shibuya, M., Raab, S., & Plate, K. H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5527-08.2009 · Cited by 128
Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization
Lambert, V., Munaut, C., Jost, M., Noël, A., Werb, Z., Foidart, J., & Rakic, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64401-x · Cited by 120
Self-citationPlacenta growth factor expression is correlated with survival of patients with colorectal cancer
Wei, S.-C. (2005) · Gut · doi:10.1136/gut.2004.050831 · Cited by 116
Stefanik, D. F., Fellows, W. K., Rizkalla, L. R., Rizkalla, W., Stefanik, P. P., DeLeo, A. B., & Welch, W. C. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1013329832067 · Cited by 115
Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases
Paternostro, C. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i3.281 · Cited by 115
Gerber, H., Wu, X., Yu, L., Wiesmann, C., Liang, X. H., Lee, C. V., Fuh, G., Olsson, C., Damico, L. A., Xie, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611492104 · Cited by 109
Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., & Giacca, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00034-0 · Cited by 108
Self-citationBae, D., Kim, T., Li, G., Yoon, W.-H., & Chae, C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1564 · Cited by 108
Angiozyme: A Novel angiogenesis inhibitor
Weng, D. E., & Usman, N. (2001) · Current Oncology Reports · doi:10.1007/s11912-001-0014-7 · Cited by 107
Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor
Marcellini, M., Luca, N. D., Riccioni, T., Ciucci, A., Orecchia, A., Lacal, P. M., Ruffini, F., Pesce, M., Cianfarani, F., Zambruno, G., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051041 · Cited by 106
Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone
Petty, W. J., Miller, A. A., McCoy, T. P., Gallagher, P. E., Tallant, E. A., & Torti, F. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1957 · Cited by 102
Impaired Adipose Tissue Development in Mice With Inactivation of Placental Growth Factor Function
LIJNEN, H. R., Christiaens, V., Scroyen, I., Vörös, G., Tjwa, M., Carmeliet, P., & Collen, D. (2006) · Diabetes · doi:10.2337/db06-0526 · Cited by 100
Self-citationYoo, S., Yoon, H.-J., Kim, H., Chae, C., Falco, S. D., Cho, C., & Kim, W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24289 · Cited by 95
Luttun, A., Brusselmans, K., Fukao, H., Tjwa, M., Ueshima, S., Herbert, J., Matsuo, O., Collen, D., Carmeliet, P., & Moons, L. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00677-0 · Cited by 93
Self-citationAntiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.
Itokawa, T., Nokihara, H., Nishioka, Y., Sone, S., Iwamoto, Y., Yamada, Y., Cherrington, J. M., McMahon, G., Shibuya, M., Kuwano, M., et al. (2002) · PubMed · Cited by 84
Gannon, G., Mandriota, S. J., Cui, L., Baetens, D., Pepper, M. S., & Christofori, G. (2002) · PubMed · Cited by 78
Self-citationDupuy, É., Hainaud, P., Villemain, A., Bodevin, E., Brouland, J., Briand, P., & Tobelem, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00086-2 · Cited by 77
Self-citationPlacenta growth factor (PlGF) mRNA expression in brain tumors
Nomura, M., Nomura, M., Yamagishi, S., Harada, S.-I., Yamashima, T., Yamashita, J., & Yamamoto, H. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1006198422718 · Cited by 73
Ho, M., Chen, C., Lee, H., Hsieh, F., Shun, C., Chang, C., Lai, Y.-T., & Lee, P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.10.005 · Cited by 69
Davidoff, A. M., Nathwani, A. C., Spurbeck, W. W., Ng, C. Y., Zhou, J., & Vanin, E. F. (2002) · PubMed · Cited by 62
Steenkiste, C. V., Geerts, A. M., Vanheule, E., Vlierberghe, H. V., Vos, F. D., Olievier, K., Casteleyn, C. R., Laukens, D., Vos, M. D., Stassen, J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.068 · Cited by 62
Self-citationRoncal, C., Buysschaert, I., Gerdes, N., Γεωργιάδου, Μ., Овчинникова, О. А., Fischer, C., Stassen, J. M., Moons, L., Collen, D., Bock, K. D., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp380 · Cited by 62
Self-citationMatsumoto, K., Suzuki, K., Koike, H., Okamura, K., Tsuchiya, K., Uchida, T., Takezawa, Y., Kobayashi, M., & Yamanaka, H. (2003) · PubMed · Cited by 56
Lassen, U., Nielsen, D. L., Mau‐Sørensen, M., Winstedt, L., Niskanen, T., Stenberg, Y., Pakola, S., Stassen, J. M., & Glazer, S. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.609 · Cited by 52
Dawson, M., Duda, D. G., Chae, S., Fukumura, D., & Jain, R. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006525 · Cited by 51
Molinas, C. R., Campo, R., Dewerchin, M. A., et al. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00768-4 · Cited by 51
Self-citationGille, J., Heidenreich, R., Pinter, A., Schmitz, J., Boehme, B., Hicklin, D. J., Henschler, R., & Breier, G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22531 · Cited by 43
Elevated levels of placental growth factor represent an adaptive host response in sepsis
Yano, K., Okada, Y., Beldi, G., Shih, S., Bodyak, N. D., Okada, H., Kang, P. M., Luscinskas, F. W., Robson, S. C., Carmeliet, P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080398 · Cited by 42
Self-citationXu, L., & Jain, R. K. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0141 · Cited by 41
Yang, S., Cheng, H., Cai, J., Cai, L., Zhang, J., & Wang, Z. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02538.x · Cited by 26
Cheng, D., & Sefton, M. V. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0470 · Cited by 19
Placenta Growth Factor is a Survival Factor for Human Malignant Mesothelioma Cells
Albonici, L., Doldo, E., Palumbo, C., Orlandi, A., Bei, R., Pompeo, E., Mineo, T. C., Modesti, A., & Manzari, V. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200216 · Cited by 9
Lassen, U., Nielsen, D. L., Mau‐Sørensen, M., Rønnengart, E., Eldrup, K., Bentzon, K., Winstedt, L., Niskanen, T. M., Pakola, S., Stassen, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-09-a111 · Cited by 7
Cited by
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Self-citationShibuya, M. (2011) · Genes & Cancer · doi:10.1177/1947601911423031 · Cited by 1,748
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Self-citationNormalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Metadata
- Authors
- Van de Veire, S., Stalmans, I., Heindryckx, F., Oura, H., Tijeras-Raballand, A., Schmidt, T., Loges, S., Albrecht, I., Jonckx, B., Vinckier, S., Van Steenkiste, C., Tugues, S., Rolny, C., De Mol, M., Dettori, D., Hainaud, P., Coenegrachts, L., Contreres, J.-O., Van Bergen, T., Cuervo, H., Xiao, W.-H., Le Henaff, C., Buysschaert, I., Masouleh, B. K., Geerts, A., Schomber, T., Bonnin, P., Lambert, V., Haustraete, J., Zacchigna, S., Rakic, J.-M., Jiménez, W., Noël, A., Giacca, M., Colle, I., Foidart, J.-M., Tobelem, G., Morales-Ruiz, M., Vilar, J., Maxwell, P., Vinores, S. A., Carmeliet, G., Dewerchin, M., Claesson-Welsh, L., Dupuy, E., Van Vlierberghe, H., Christofori, G., Mazzone, M., Detmar, M., Collen, D., & Carmeliet, P.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 141
- Issue
- 1
- Pages
- 178-190
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2029089767
- Cited by
- 256
- References
- 65
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.